From October 18 to 19, the 13th Advanced Hemostasis Seminar took place in Budapest with 200+ attendees on-site from countries in East and North Europe, Middle East, Africa, and India.
The 9th International Autoimmunity Seminar took place on the 20th and 21st of October 2022, marking the return of in presence scientific events, gathering after 2 cancellations due to COVID-19 pandemic.
The 3rd EEMEA Acute Care Experts Meeting was held on 18-19 October with more than 100 acute care experts representing 36 countries from East and North Europe, Middle East, Africa and India.
In October, the EEMEA team promoted the new virtual reality (VR) application for HemoCell Specialized Lab Automation during 2 customer events in Hungary and Poland.
In 2022 we focused part of our effort to empower the care of women with bleeding and thrombotic disorders through education and social responsibility.
On 20th October, the Acute Care Diagnostics Marketing Team kicked-off an in-person session in Budapest dedicated to New Products Controlled Release for all the distribution partners and affiliates in EEMEA.
Dear Werfen Partner,
Our e-learning community is continuously growing, reaching more and more people globally: this month, Werfen Academy has reached a key milestone with more than 20,000 learners enrolled worldwide.
At Werfen, we invest a lot in taking care of every employee and special attention is always dedicated to key turning points in career paths.
On November 15 Werfen hosted a worldwide virtual educational event "Optimizing Patient Safety through Comprehensive Bleeding Management in Cardiac Surgery" and EEMEA participation was a great success!
A selected group of distributors from Switzerland, South Africa and Romania and end-users from France, Switzerland and Romania were invited to join the EEMEA team in Basel for the Hemostasis Standardization Symposium.
Werfen and Bambini cardiopatici nel mondo joined forces for World Heart Day to raise awareness on Cardiovascular and Congenital heart diseases with experts in the field to have a virtual "Question time with Cardiac Specialists" session.
Clinical Software specialists from all the Werfen affiliates met in Barcelona from October 25th to 27th for the 4th WW Clinical IT Support Meeting. It was the first time after the pandemic the IT department finally met in presence to discuss IT support for Werfen Products.
EEMEA is proud to have won the NOVA View® tender in Hungary in November along with the effort of our Werfen Hungary Affiliate, against tough competition.
Back from Holiday season, restart the engines
We hope you all had a very relaxing and pleasant summer break! September is back and, even for the latecomers, it’s time to restart our engines and to be fully immersed in our exciting activities. Many events are waiting for us this fall. Go through our news and discover the second semester Application & Service training courses. Have a look to the main congress reports; be prepared for our upcoming Advanced Seminars next month in Budapest. We are going to disclose the latest news and courses in Werfen Academy, do not miss them! Also, a corner is dedicated to Talent retention in the Human Resources area.
All this and much more is waiting for you. Have a great restart of your activities!
EEMEA Team just closed its annual HALF TERM MEETING, held in hybrid version from July the 04th to July the 6th. The hubs involved were Milan and Dubai for a total of 38 people only 3 of which connected virtually.
We are pleased to provide a report of competitive activities performed during the 74th AACC (Chicago – USA, July 24/28, 2022). Click here to visit the congress website.
Werfen Poland and the rest of the team in EEMEA with the support of the SBU installed the first HemoCell in Poland and the second in EEMEA in May 2022.
After almost 2.5 years of global pandemic, we are now gradually returning to our previous lifestyle, and we hope that soon we will start living our lives as before COVID-19 outbreak.
Beginning May 26, 2022, the In Vitro Diagnostic Regulation (EU) 2017/746 (IVDR) compliance is mandatory for all non-sterile Class A devices.
Did you see our new LinkedIn campaign? Hope so! Fully dedicated to Werfen EEMEA, the brand new campaign "Did you know... EEMEA" has been launched in June with the aim of raising awareness on the Werfen EEMEA structure and activities.
Dear readers,
This last month of May, we held our 8th EEMEA Partnership Meeting in Milano with the participation of more than 150 attendees among Werfen employees and Partners. We want you to thank you all for taking part in our Meeting and making it a success!
The EEMEA Scientific Seminars are back and in presence after 2 years of absence! The return of in-person events is one of the 6 top event trends according to the 2022 Global Meetings and Event Forecast and we fully agree!
Starting with the grand piano on stage, a charming blue carpet and the theater curtains opening projected on the big ledwall, the leitmotiv of the 8th EEMEA Partnership Meeting was unmistakably clear.
It was the “theater theme” that worked as the fil rouge of the event, specifically the opera house – an authentic Italian excellence.
Werfen and AFMS organized the first Partnership meeting held from March 22nd to March 24th in Dubai, UAE.
The cooperation between Werfen and its local KSA partner, AFMS, is unique.
In April, we launched our podcast channel EEMEA Talks with a first series on the History of Hemostasis.
Following a very successful launch of Aptiva in 2021, Werfen EEMEA had already installed the very first unit in December 2021.
The team did not rest on their achievement after this success, but instead became even more enthused, installing another unit in January 2022.
Dear Werfen Partners,
Werfen Academy in EEMEA is continuously growing in number of users and attended courses. Furthermore, a new competitors’ tool has just been released, so keep on reading this section until the end!
This is the third report since Werfen became a signatory member of the UN Global Compact. In it you will find all the initiatives we carried out in 2021 which contributed to the advancement of the UN Sustainable Development Goals (SDGs).
In 2022 we focused part of our effort to empower the care of women with bleeding and thrombotic disorders through education and social responsibility.
The year 2021 ended with EEMEA winning the BIO-FLASH tender in Serbia, with the big effort of our local distributor, Makler, against a tough competition. Thanks to this, Werfen would now be able to enter the Serbian market.
Many of you will probably have watched at least 1 episode of the Autoimmune Webinar Series that we launched in early 2020. But did you ever wonder how these webinars are made? For those who did, click read more for a short tour behind-the-scenes!
The International Congress on Antiphospholipid Antibodies (ICAPA) is held every three years to discuss recent advances and future directions in Antiphospholipid Syndrome (APS).
Dear Good Morning EEMEAI readers!
Our 12th issue is ready and full of interesting articles to be devoured! In this first edition of 2022 we have some exciting updates for you: from the new premises of the Learning Center in Dubai, from the new organizational structure of the Customer Support team to our monthly Werfen Academy updates. A big portion of edition 12 will be dedicated to our People as we are presenting 2 very interesting new Human Resources initiatives and last but certainly not least we are starting this issue with saying goodbye to Paolo... just a few more months to enjoy his presence and experience!
We cannot reveal anything yet but look out for the June issue! It will be released just after our Partnership meeting and it promises to be a real special edition!
The Editorial Board: Ksenia, Mariella, Anurag, Luca
Pepe Zamora, Director EEMEAI, kicked off the meeting by presenting and celebrating our achievements in the region.
A unique feature of this Kickoff was the high level of interaction in spite of the virtual plaform, where partners and Werfen collaborators interacted to discuss several topics of interest in the current business environment.
Call-to-Actions for 2022 were an integral part of the EEMEAI 2022 Kick-off. The Hemostasis team aimed to translate our Purpose Statement into CTAs by making a connection between why we do what we do as an organization and what we do in Hemostasis in EEMEAI.
On March 8, International Women's Day, the EEMEAI marketing team hosted a virtual conference to raise awareness on Bleeding and Thrombotic Disorders in Women.
Back in 2016, Werfen established the first office in the Middle East, in the United Arab Emirates, Dubai, in response to the growing demand for Werfen products in the region.
ERA, European Renal Association is a major association of physicians having the goal of promoting the advancement of medical science fundamental and clinical advances in the field of nephrology, dialysis, renal transplantation, hypertension, and related subjects.
Dear Werfen Partners,
2022 has started with great energy and success for Werfen Academy EEMEAI: we reached the 1thousand users milestone!
Werfen implemented Strategic Selling in its commercial methodologies since 2019, as a complementary skillset in addition to the ValueSelling Framework, initiated in 2018.
Werfen’s strategy consists in a high level of specialization in selected IVD segments in which we are able to provide best-in-class solutions for our partners and Customers around the world.
In a world becoming more and more international and globalized, Werfen EEMEAI has decided to join forces with goFLUENT and accept the linguistic challenge and provide employees with a new tool.
It is the common opinion of the leaders of many organizations to think about Collaboration as a Value to cultivate but not as a skill to teach!
Dear Good Morning EEMEAI readers,
We are proud of proposing this new issue, the last for 2021, with plenty of engaging articles: from Success Stories to our Corporate Social Responsibility initiatives, from Werfen Academy corner to technical updates on GEM Premier & HemoCell.
For the first time, GEMweb Live is in clinical use―at three hospitals in Spain. A real-time onscreen data viewer, GEMweb Live consolidates test results from ROTEM, VerifyNow, Hemochron and GEM Premier systems, at the point of care, all on one screen.
In September, King Faisal Specialty Hospital and Research Center (the hospital) confirmed that all inhouse Thrombotic Thrombocytopenic Purpura (TTP) diagnosing and monitoring will be done with HemosIL AcuStar ADAMTS13 Activity assay in a 2-year deal, that includes a Bio-Flash analyzer for its autoimmunity laboratory.
Diagnostic testing, through accurate results, enables the health care providers in effective delivery of care in today's complex healthcare system, particularly in acute care settings.
On September 17th, World Patient Safety Day, Werfen EEMEAI conducted an educational event that received over 8700 registrations, demonstrating the commitment of EEMEAI colleagues, distribution partners and customers towards Patient Safety, as envisioned by Werfen.
As part of our strategy to continue supporting our Partners with the implementation of IT solutions, we are very pleased to release the first HemoHub™ Installation Requirements & Checklist Guide
Dear Werfen Partners,
In this issue we are glad to share another update of the milestones reached during the past months, a success story from Poland about Werfen Academy contribution in tenders, and to launch a new customer facing tool.
Avoiding or delaying a difficult conversation can hurt your relationships and create other negative outcomes. It may not feel natural at first, especially if you dread discord, but you can learn to dive into these tough talks by reframing your thoughts.
We treat this topic because it is our belief that having a psychologically safe workplace can help organizations cope with future and unknown risks.
It is our pleasure to communicate that in July 2021 Abdullah Fouad Medical Systems, in collaboration with the EEMEAI team, successfully performed the first HemoHub installation in the Kingdom of Saudi Arabia.
Dear Werfen Partners,
Here we are with the second update of the milestones reached by Werfen Academy during the past few months, thanks to your efforts and commitment.
EEMEAI Team is eager to resume face-to-face events! We have been obliged to substitute 2020 edition of Advanced Seminars with digital activities, but we are working hard to come back with live edition.
Food for thought
A recent article by McKinsey & Company about the future of workplace after the pandemic, put in evidence how lack of information about the future of workplace, due to the long period of isolation and distance from the workplace, is a source of stress and anxiety:
12th of July 2021 will be remembered as the Werfen New Logo Launch Date. The new Werfen logo is modern, strong and singular, signifying unity in the Company’s quest to deliver innovation after innovation, for every patient whose life could depend upon the quality of a test result.
COVID-19 couldn’t stop our commitment and dedication in sharing the knowledge of our Systems and Solutions.
The Remote Approach presented us with some difficulties, but in the long run also gave a lot of gratification.
New EEMEAI project alert!
Tuesday 6th July was the very first meeting of this new ECG EEMEAI Clinical Group, with the objective of improving clinical scientific knowledge and awareness within affiliate and distributor teams, and to share experience among peers focused on Patient Blood Management (PBM) and Whole Blood Hemostasis (WBH).
One of the key aspects of clinical value selling is augmentation of ecosystem and market advocacy in the focus areas. Enablement and empowerment of the end user, in terms of clinical application of Werfen products and solutions, continues to drive clinical marketing strategy.
Corporate Social Responsibility is a very dear topic to Werfen at corporate and local level.
Werfen hub in Milan is being working on a corporate social responsibility project we are proud of: both EEMEAI and Italy subsidiaries, who share the same HQ, decided to join forces and help regularly one of the oldest Onlus in Milan: Pane Quotidiano – which means “daily bread”.
EEMEAI 2021 Half Term Meeting has been the very first in person since January 2020.
16 months ago, before the pandemic spread like wildfire, Milan, Dubai and Russia hubs met in Palermo for the 2020 Kick Off, after that we could no more be in the same place in person altogether.
The third floor of the Werfen building in Milan for a day became a TV Studio: EEMEAI department launched its official EEMEAI Channel to broadcast the 7th EEMEAI Marketing and Support Meeting Plenary Session “fully connected, fully committed”.
On May 26th and May 27th, we had the pleasure to spend several hours together each day sharing Hemostasis Diagnostics updates.
We have just concluded our 7th EEMEAI Meeting, another virtual event due to the pandemic, not the first, as we adapt very rapidly to the new times and we were able to be fully connected and fully committed in spite of the difficulties.
After the energetic 7th EEMEAI Meeting Plenary session, the mission and vision of the Werfen EEMEAI Ecosystem with our partners and colleagues was clear and inspiring. The EEMEAI Acute Care Diagnostics (ACDx) Marketing Meeting
O tempora, o mores! This popular exclamation used by the Latin orator Cicero fits perfectly in the present days in which our lives rapidly changed together with our habits.
Still remember our days in Rome and how the previous Distributor Meeting was in 2019… However, during the last 18 months we repeated many times to ourselves that we had to adapt to the new normality, being resilience and accepting the challenges from this VUCA world… And of course, we did it once again…
We are very proud to share with all our partners that Werfen has decided to join the United Nations Global Compact (UNGC) this year.
The United Nations Global Compact (UNGC) represent the world’s largest corporate sustainability initiative.
Keeping our Partners fully updated on the latest news and product information from our Business Lines is one of the major goals we have at EEMEAI.
Therefore, with the support of Werfen IT dpt., we have developed a new and more innovative repository, that gathers all Service and Marketing documentation for Blood Gas, Clinical Chemistry, Hemostasis, PBM and WBH.
In September 2019 EEMEAI affiliate and Werfen Italy affiliate joined forces and decided to make a small change to start their partnership with WAMI company.
The impact is more than Half a million litres of drinking water for needing communities.
IVD market in the beginning used to be simple: the supplier provided instruments and reagents to the customer who could therefore analyze their patients’ samples.
As every market, also IVD one evolved following the society’s evolution.
Virtual is the name of the day and going viral has really gotten a new meaning this last year. We at Mediq have also been active on the virtual scene, both as an exhibitor and as a visitor … all in all I must say that virtual is better than nothing, but a salesperson longs for face-to-face meetings!
Continuous education, operator training and accreditation support: these are the main and most frequently unmet needs in clinical settings. About one year ago, Werfen EEMEAI launched a top-quality eLearning platform
Our EEMEAI team is large, diverse and spread all over the world. Despite the new reality brought on by the COVID-19 pandemic, occasions to connect and bond are still fundamental. What better occasion than the 2021 Kick Off?

